The ability to precisely modify the mouse genome is an invaluable tool for any researcher. If an artificial epitope sequence is integrated into target loci in specific cell types, it is possible to generate mice with these cells specifically tagged with the epitope, which can be used for many subsequent studies. Homologous recombination and the Cre/loxP system have been used to generate targeted and conditional transgenic mice, which have provided the basis for many studies into gene function. However, in recent years, improvements in technology have led to the development of RNA and protein based methods of specifically editing DNA sequences at user-selected loci. This thesis aimed to investigate the effectiveness of the novel gene targeting methods TALEN and CRISPR/Cas9. It also aimed to utilize different strains of mice generated using the Cre/loxP system in Trichuris muris, an animal infection model of the human disease Trichuris trichiura. TALENs use a pair of protein-based monomers specific to the sense and anti-sense strand of a target DNA sequence to dimerise a FokI nuclease and initiate a deletion in the genome. As a study into the practical use of this emerging technology TALENs were generated to target Oct-4 (a stem cell marker) in order to integrate an artificial epitope sequence, which could be used for enrichment experiments. The CRISPR/Cas9 is a very efficient RNA-based system used for modifying a target sequence. This system has been utilized to integrate an epitope sequence into the Rosa26 locus, downstream of a floxed STOP codon. This allows for expression of the epitope following the introduction of tissue restricted Cre recombinase. IL-1 is an important cytokine in the immune response towards T.muris. IL-1R1 was conditionally removed in CD4 cells and the role of IL-1 signaling in developing Th1, Th2 and Th17 responses was then studied. Interestingly, IL-1R1fl/fl CD4Cre mice could generate Th1 and Th2 response but showed a reduction in IL-22 and IL-17 production, two key Th17 cytokines. Infected IL-1R1fl/fl CD4Cre mice also displayed increased gut morphology and goblet cell hyperplasia. Therefore, it was concluded that IL-1 signaling from CD4 cells has an important role in host defense and the development of a full Th17 response. It was also shown that removing IL-1R1 in naïve mice had no affect on lymphocyte development. IL-10 is an anti-inflammatory cytokine expressed by gut macrophages, which contributes to homeostatic control of the immune system. IL-10R was specifically removed in the macrophage specific Cre lines LysMCre and also in CX3CR1Cre as a way of comparing the two Cre drivers. The mice were then infected with T.muris and displayed significant inflammation and also failure to expel the worms in the LysMCre model. This suggests a role for this model in future studies of gut macrophages. Clearly, animal models are very important in the study of gene function and also as a method of assessing the application of new technologies such as CRISPR/Cas9. Future work with the artificial epitope specifically targeted into important cell lines will form the basis of many important studies directly applicable to human disorders. As the technologies improve, the scope for developing therapeutics increases and genetic modification has an immeasurable role to play.

Osteoarthritis (OA) is the most prevalent arthritis in the world with increasing numbers of people expected to acquire the disease as the population ages. Therapies commonly used to manage the disease have limited efficacy and some carry significant risks. Current data suggest that the anti-inflammatory cytokine IL-1 receptor antagonist (IL-1Ra) can alter the inflammatory response and cartilage erosion present in OA. Intra-articular gene expression of IL-1Ra has shown promising results in animal models to provide symptomatic improvement and minimize osteoarthritic changes. Orthogen AG (Dusseldorf, Germany) has developed a method to produce an autologous conditioned serum (ACS) rich in IL-1Ra marketed as Orthokine®. Study participants treated with ACS have improved pain and function; however, these results are preliminary and need confirmation. If ongoing trials prove that ACS can retard cartilage degeneration and reduce inflammation, the management of OA would be dramatically altered, perhaps providing a mechanism to prevent the disease or at least its progression.

No description available.

No description available.

No description available.

<p>Despite the advanced knowledge of the mechanisms of influenza infection and improved vaccines, Influenza A Virus still causes a life-threatening respiratory disease, especially during pandemics. Past investigations have proposed a synergism between Influenza A virus and a simultaneous or subsequent bacterial superinfection as the predominant cause of death. The recent development of animal models to study these heterologous infections has shed light onto the diverse mechanisms by which Influenza A Virus may increase the susceptibility to contract a secondary bacterial infection. These studies suggested an important role for the innate immune system in mediating such disease. We developed a model of heterologous infection combining Influenza A Virus and <em>Bordetella parapertussis</em> that demonstrated a critical role for MIP-2 to drive pulmonary neutrophilia in the pathology associated with bacterial superinfection of influenza. However, the origin of this increased MIP-2 production and the mechanisms underlying the immunopathology remained to be elucidated. The present studies proposed IL-1β overproduction as the upstream cause of the increased MIP-2 production observed in heterologous infection. This exaggerated IL-1β production was likely related to the increased bacterial burden observed in heterologously infected mice. This study also demonstrated that reduction in IL-1β production by blockade of the inflammasome seemed to provide an improvement in the clinical symptoms and the immunopathology of the disease. Thus, interventions to attenuate the exacerbated bacterial burden and the inflammatory responses derived from the subsequent IL-1β overproduction should be further investigate as possible therapeutic approaches to treat bacterial superinfections.</p> / Master of Science (MSc)

No / Background  Interleukin (IL)-33 is a member of the IL-1 family and has been implicated in Th2-driven allergic diseases such as atopic dermatitis (AD) and asthma. The principal Th2 cytokine IL-4, found highly expressed in acute allergic eczema, is known to downregulate human β-defensin 2 (hBD2) expression in human keratinocytes and this is associated with superinfection in patients with AD. Objectives  To investigate the effect of IL-33 on the expression of hBD2 in human keratinocytes. Methods  hBD2 production by stimulated keratinocytes was measured by enzyme-linked immunosorbent assay. Results  Our results showed that serum is a very potent inducer of hBD2 and 2·5% human serum was much more potent in inducing hBD2 than 20 ng mL−1 of tumour necrosis factor-α. Interestingly, serum from patients with AD showed an impaired ability to induce hBD2 in normal keratinocytes. IL-33 significantly downregulated serum-induced hBD2. The downregulatory capacity of IL-33 was found to be 1·5- to 2-fold weaker compared with IL-4. Conclusions  Our data suggest that IL-33 can significantly contribute to the decreased expression of hBD2 in acute eczematous reaction clinically characterized by spongiosis and oozing – thus indicative for contact of the epidermis with serum components.

IL-1 receptor/Toll-like receptor (IL-1R/TLR) supefamily represents a group of proteins that share highly conserved TIR domain in their cytoplasmic region. Signal transduction mediated by TIR-containing proteins involves the activation of NF-κB transcription factor and thus the members of this superfamily play a key role in many physiological responses related to innate immune defense and inflammation. SIGIRR (single immunoglobulin IL1R-related molecule) is a recently discovered member of the IL-1R family, however it differs from the other group members by its unique structural features. SIGIRRhas been so far considered to be an 'orphan' receptor as no SIGIRR ligand has been identified yet. Moreover, SIGIRR itself is not capable to induce the NF-κB activation. Instead, SIGIRR is supposed to act as a negative regulator for IL- 1Rs/TLRs mediated inflammation. Its inhibitory function has been implemented in several signalling pathways in various cell types and tissues including the kidney, the digestive tract and the lung. Recent reports also suggest that SIGIRR could play a role in early embryonic development. The main aim of this thesis is to characterize the mechanism how SIGIRR negative regulatory function in IL-1R/TLR signalling pathway is delivered. Here we describe the establishment of...

Este estudo se propôs a avaliar o efeito do gás sulfídrico (H2S), produzido endogenamente em mamíferos, na sinovite induzida pela injeção intra-articular de carragenina (CGN) no joelho de ratos Wistar (250 g). Ratos foram tratados (-60 min) com indometacina, o inibidor da cistationina <font face=\"Symbol\">g-liase DL-propargilglicine (PGly) ou doador de H2S reagente de Lawesson ( LR).Os parâmetros funcionais e bioquímicos foram avaliados 4h após. Ratos com sinovite exibiram dor, alodinia e edema articular. Na cavidade articular foram mensurados níveis elevados de neutrófilos (> MPO), nitração de resíduos protéicos (3-NT), atividade da iNOS, NOx-, caspase-1, IL-1<font face=\"Symbol\">&#946 e via NF-<font face=\"Symbol\">kB. O LR ou indometacina, mas não PGly, reduziu significativamente a nocicepção, edema e marcadores inflamatórios, exceto iNOS, NOx-, 3-NT e NF-<font face=\"Symbol\">kB. A PGly não modificou a dor e inflamação, mas aumentou o numero de macrófagos e atividade da iNOS (NOx-) e AP-1. Conclui-se que, enquanto a administração exógena do LR produz efeitos antiinflamatórios e anti-nociceptivos, o H2S endógeno exerce pouco efeito anti-sinovite. / In this study we evaluated the effects of exogenous and endogenous H2S on Wistar rat knee synovitis induced by the intra-articular injection of carrageenan (CGN). One hour prior to CGN injection, Rats were pre-treated with indomethacin, an inhibitor of H2S formation (DL-propargylglycine) or an H2S donor Lawessons reagent (LR). CGN evoked knee inflammation, as characterized by impaired gait, secondary allodynia of the hindpaw, joint swelling, neutrophil infiltration, increased MPO, 3-NT residues, inducible NOS (iNOS) activity and NOx-, caspase-1 and NF-<font face=\"Symbol\">kB activation. Pretreatment with LR or indomethacin significantly attenuated the pain and all the inflammatory / biochemical changes, except for the increased iNOS activity, NOx- and 3-NT. PGly potentiated synovial iNOS activity (and NOx-), enhanced macrophage infiltration and AP-1 activation, but had no effect on oedema and pain. Whereas exogenous H2S delivered to the knee joint can produce a significant anti-inflammatory and anti-nociceptive effect, locally produced H2S exerts little immunomodulatory effect.

A lesão tecidual é um dos efeitos locais descritos nos envenenamentos botrópicos. Toxinas isoladas, como: a jararagina (JAR) e bothropstoxina-I (BthTX-I), obtidas dos venenos de B. jararaca e B. jararacussu, respectivamente, induzem intensa resposta inflamatória e lesão tecidual, porém apresentam diferentes mecanismos de ação. Como descrito, a resolução da lesão tecidual envolve a interação entre mecanismos de reparo do tecido e o sistema imune. Neste contexto, a resposta inflamatória é iniciada por meio da detecção de sinais de dano tecidual agudo devido a distúrbios da homeostasia resultantes ou não de agentes microbianos (DAMPs) e/ou por reconhecimento de padrões moleculares associados a patógenos (PAMPs). Uma vez induzida, a resposta inflamatória está envolvida tanto no processo de lesão visando a eliminação do agente indutor, assim como no reparo tecidual. Diversos receptores estão envolvidos no reconhecimento de PAMPs e DAMPs como os transmembrânicos representados pelos do tipo Toll, e os citosólicos que compreendem complexos proteicos que formam os inflamassomas. Estes complexos multiproteicos citosólicos podem participar da indução da resposta imune inata por ativação de caspase-1 com consequente liberação de IL-1&#946, que pode resultar em morte celular. Considerando o exposto, o objetivo deste trabalho foi estudar a participação de inflamassoma na resposta inflamatória no tecido muscular de injeção das toxinas, a capacidade da BthTX-I e JAR de induzir a ativação de inflamassoma em macrófagos e os mecanismos moleculares envolvidos nesse processo. O estudo da migração de neutrófilos e macrófagos para o músculo gastrocnémio de animais C57BL/6 ou deficientes em caspase 1/11 (Caspase 1/11-/-) ou NLRP3 (NLRP3-/-) injetados com JAR e BthTX-I permitiu verificar que o inflamassoma NLRP3 participa da migração destas células inflamatórias para local de injeção das toxinas. A análise da produção de IL-1&#946 nas culturas de macrófagos peritoneais incubados com JAR e BthTX-I (6 e 24h) mostrou que somente a BthTX-I foi capaz de induzir a secreção desta citocina por um mecanismo dependente de caspase 1/11, ASC e NLRP3 e independente de IPAF. A incubação de macrófagos humanos com as toxinas permitiu verificar que ambas as toxinas induziram a secreção de IL-1&#946 dependente de caspase 1, porém esta produção foi significativamente maior em resposta à BthTX-I. Nos macrófagos peritoneais de camundongos observamos a relação entre a secreção de IL-1&#946 e morte celular em ensaio de incorporação do brometo de etídio nas culturas incubadas com BthTX-I por 24h e não com a JAR. Visto que ambas as toxinas injetadas via intramuscular induzem resposta inflamatória intensa, foi analisado o efeito delas sobre a viabilidade e secreção de IL-6 e MCP-1 em miotubos C2C12. Os resultados mostraram que somente a BthTX-I induz efeito miotóxico sobre esta linhagem celular. Além disso, pudemos verificar que BthTX-I induz altos níveis de IL-6 e MCP-1 quando comparados aos obtidos com a JAR. Visto que a BthTX-I induziu alta secreção de MCP-1 pelos miotubos C2C12, em experimento in vivo realizado em camundongos C57BL/6 ou deficientes em CCR2 (CCR2-/-) pode ser observada a dependência da interação entre MCP-1 e o CCR2 para a migração dos macrófagos em resposta a injeção de BthTX-I. Em culturas de miotubos incubados com as toxinas pôde ser observada alta liberação de ATP induzida pela BthTX-I in vitro. Em outros experimentos foi estudada a capacidade do sobrenadante de miotubos incubados com BthTX-I de induzir a secreção de IL-1&#946 pelos macrófagos in vitro. Os resultados mostraram a produção de IL-1&#946 nessas culturas de macrófagos, assim como a produção desta citocina em macrófagos incubados com BthTX-I juntamente com ATP. A hidrólise do ATP no sobrenadante da cultura de C2C12 estimulada com BthTX-I aboliu a secreção de IL-1 pelos macrófagos in vitro. Além disso, foi observada a inibição da produção de IL-1&#946 nas culturas de macrófagos primados com LPS e incubados com a BthTX-I em condições de altas concentrações de KCl sugerindo papel relevante do efluxo de K+ na produção de IL-1&#946 induzida pela BthTX-I. Em conjunto, os resultados acrescentam novas informações sobre o potencial inflamatório da JAR e BthTX-I, quanto à ação destas toxinas em macrófagos, ativação de inflamassoma e células musculares. / Tissue damage is one of the local effects described in bothropic envenomations. Isolated toxins, such as jararhagin (JAR) and bothropstoxin-I (BthTX-I), obtained from B. jararaca and B. jararacussu venoms, respectively, induce intense inflammatory response and tissue injury, however mediated by distinct mechanisms. As described, resolution of tissue injury involves the interaction between mechanisms of tissue repair and the immune system. In this context, the inflammatory response is initiated by detecting of signs of acute tissue damage due to disorders of homeostasis resulting from distinct agents (DAMPs) and / or recognition of pathogens associated molecular patterns (PAMPs). Once induced, the inflammatory response is involved both in the injury process for the elimination of the pathogenic agent, as well as in the tissue repair. Several receptors are involved in the recognition of PAMPs and DAMPs as the transmembrane receptors such as the Toll-like, and the cytosolic ones that comprise protein complexes - inflammasomes. These cytosolic multiprotein complexes may participate in the induction of the innate immune response by activation of caspase-1 with consequent release of IL-1&#946, which may result in cell death. Thus, we aimed to study the role of inflammasome on the inflammatory response in muscular tissue of JAR and BthTX-I injection, the ability of BthTX-I and JAR to induce the activation of inflammasome in macrophages and the molecular mechanisms involved in this process. The analyses of the neutrophils and macrophages migration in gastrocnemius muscle of C57BL/6 or Caspase 1/11 (Caspase 1/11-/-) or NLRP3 (NLRP3-/-) deficient mice injected with JAR e BthTX-I allow us to verify that NLRP3 inflammasome participates in these cells migration for the local of the toxins injection. The detection of IL-1&#946 on supernatants from macrophage cultures incubated with JAR or BthTX-I (6 e 24h) showed that only BthTX-I was able to induce this cytokine secretion by a mechanism dependent of caspase 1/11, ASC and NLRP3 and independent of IPAF. The incubation of human macrophages with the toxins demonstrated that both toxins induced IL-1&#946 secretion, however this production was significantly higher in response to BthTX-I. On murine macrophage cultures it was verified the correlation between the IL-1&#946 secretion and the cell death in the incorporation of ethidium bromide assay of cultures incubated with BthTX-I during 24h and not with JAR. Since that both toxins injected in the muscle induced intense inflammation, it was analyzed the effect of both toxins on the viability and the secretions of IL-6 and MCP-1 by C2C12 myotubes. The results showed that only BthTX-I induces a myotoxic effect on this cell line. Furthermore, it was verified that BthTX-I induces high secretion of IL-6 and MCP-1 when compared with those induced by JAR. Considering that BthTX-I induces high levels of MCP-1, in in vivo experiment using C57BL/6 and CCR2 deficient (CCR2-/-) mice it was observed that the interaction of MCP-1 and CCR2 is essential for the macrophage recruitment for the toxin injection. High release of ATP was detected in C2C12 myotube cultures incubated with BthTX-I but not with JAR. In another experiments it was studied the ability of the supernatants of C2C12 myotubes incubated with BthTX-I to induce the IL-1&#946 secretion by peritoneal macrophages in vitro. The results showed the IL-1&#946 secretion in the macrophage cultures as well as the cytokne secretion in macrophages incubated with BthTX-I and ATP independent of the priming with LPS. The hydrolysis of the ATP on the supernatants of C2C12 incubated with the BthTX-I abolished the IL-1&#946 production by macrophages in vitro. In addition, it was not observed IL-1&#946 production by macrophages primed with LPS and incubated with BthTX-I in the presence of high concentration of KCl suggesting a relevant role of K&#43 efflux for this cytokine secretion in response to BthTX-I. Taken together, the results show new findings about the inflammatory effect of JAR and BthTX-I, concerning about the action of these toxins on macrophages, inflammasome activation and muscle cell.